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ABSTRACT
The DExD/H box family of proteins includes a large
number of proteins that play important roles in RNA
metabolism. Members of this family have been
shown to act as RNA helicases or unwindases,
using the energy from ATP hydrolysis to unwind
RNA structures or dissociate RNA–protein com-
plexes in cellular processes that require modulation
of RNA structures. However, it is clear that several
members of this family are multifunctional and, in
addition to acting as RNA helicases in processes
such as pre-mRNA processing, play important roles
in transcriptional regulation. In this review I shall
concentrate on RNA helicase A (Dhx9), DP103
(Ddx20), p68 (Ddx5) and p72 (Ddx17), proteins for
which there is a strong body of evidence showing
that they play important roles in transcription, often
as coactivators or corepressors through their inter-
action with key components of the transcriptional
machinery, such as CREB-binding protein, p300,
RNA polymerase II and histone deacetylases.
INTRODUCTION
The DExD/H box family of proteins is distinguished by the
presence of several conserved motifs, which include the char-
acteristic ‘DExD/H’ sequence (where x can be any amino
acid) and are highly conserved in proteins from viruses and
bacteria to humans (1–3). Based on homology with the
well-characterized DNA helicases (4) and the observation
that some prototypic members exhibit RNA helicase activity
in vitro, it has been proposed that DExD/H proteins act prin-
cipally as ATP-dependent RNA helicases. However, it is now
thought that rather than being processive RNA helicases, sev-
eral DExD/H box proteins may be acting as RNA ‘chaper-
ones’, promoting the formation of optimal RNA structures
through local RNA unwinding, or as RNPases by mediating
RNA–protein association/dissociation (5–8).
These proteins are now of major interest because they
are known to play important roles in virtually all aspects of
RNA synthesis and function, including pre-mRNA process-
ing, ribosome biogenesis, RNA turnover, RNA export and
translation, processes that involve multi-step association/
dissociation of large RNP complexes as well as the modula-
tion of complex RNA structures. Historically, most DExD/H
box proteins have been associated with such cellular pro-
cesses; indeed many members of this family were initially
identiﬁed through investigations of mutants that led to spe-
ciﬁc defects in processes such as RNA processing, ribosome
biogenesis and translation, and it is clear that the RNA
unwinding activity of these proteins is essential for their func-
tion in such processes (9). However, there is now an emerg-
ing body of evidence indicating that several members of the
DExD/H family of proteins have multiple functions in the
cell, some of which may not require their RNA helicase activ-
ity. Although DExD/H box proteins show considerable
sequence and structural homology within their conserved
‘helicase’ core, their ﬂanking N- and C-terminal domains
are highly divergent and are thought to provide speciﬁcity
of function through interaction with speciﬁc RNA substrates
or other interacting factors. A schematic ﬁgure showing
the alignment of the conserved cores of the DExD/H proteins
considered in this review and highlighting their different
N- and C-terminal extensions is included (Figure 1). These
N- and C-terminal domains through interaction with different
partners would also provide the capability for their involve-
ment in multiple processes. Of particular interest are the
reports showing that some of these proteins, through interac-
tion with components of the transcriptional machinery, play
important roles in transcriptional regulation.
In this article I shall review current evidence demonstrating
that some members of the DExD/H family have, in addition
to their established roles as RNA helicases or unwindases,
clear roles as transcriptional regulators which, in several
cases, appear to be independent of their RNA helicase activ-
ity. For this purpose, I shall concentrate predominantly on
those proteins for which most data are available in the litera-
ture: these include a member of the DExH subclass RNA
helicase A (also known as Dhx9 and nuclear DNA helicase
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doi:10.1093/nar/gkl460II), as well as the DEAD subclass proteins DP103 (also
known as Ddx20 and Gemin3) and the highly related p68/
p72 proteins (Ddx5/Ddx17). The functions of these proteins
are summarized in Table 1. I shall also brieﬂy review evi-
dence that highlights roles for DExD/H box proteins in regu-
lating transcription of genes important in cell proliferation,
cell cycle arrest or apoptosis. Finally, I shall summarize
some common perspectives and explore current ideas about
possible mechanisms by which DExD/H box proteins may
be functioning in transcription, through acting as adaptor or
bridging factors to recruit transcription factors or to stabilize
transcriptional initiation complexes, as well as the roles they
may play in linking or coupling the different processes in
which they function.
RNA HELICASE A (Dhx9)
The ﬁrst suggestion that a member of the DExD/H family was
involved in the regulation of transcription came from the ﬁnd-
ing of Kuroda et al. (10) that the Drosophila maleless DEIH
protein Mle is associated with hundreds of discrete sites along
the X chromosome in males but not in females. They sug-
gested that Mle plays a role in X chromosome dosage com-
pensation by coordinately regulating expression of genes
located on the X chromosome so that X-linked gene expres-
sion in males (XY) is equivalent to that in females (XX).
Interestingly the association of Mle with the X chromosome
appears to be RNA-dependent (11). Subsequently, two mam-
malian proteins with known helicase activity were shown to
be homologues for Mle; these included an abundant nuclear
protein from HeLa cells, called RNA helicase A (RHA)
(12), which had been shown previously to unwind double-
stranded RNA (13), and the bovine nuclear DNA helicase
II (NDHII) (14), which also had been shown to have RNA
and DNA helicase activities (15). Similar activities were
then attributed to Mle (16).
Concrete evidence that RHA (Dhx9) played an active role
in transcription came from the ﬁndings of Nakajima et al.
(17), who showed that RHA acts as a bridging factor between
the CREB-binding protein (CBP) and RNA polymerase II
(Pol II), thus cooperating with CBP to activate transcription.
The N-terminal domain of RHA, outside the conserved heli-
case core (Figure 1), was shown to interact with CBP while a
region overlapping the N-terminal domain and the helicase
domain was shown to interact with Pol II. Interestingly,
RNA helicase-defective mutants of RHA showed a decreased
ability to coactivate CBP-dependent transcription raising the
possibility that, apart from being a bridging factor, RHA may
enhance engagement of the transcriptional machinery at
responsive promoters by inducing changes in chromatin
structure through local DNA unwinding. This idea is consis-
tent with the ﬁnding that RHA interacts with double-stranded
DNA and with topoisomerase IIa (18). In a subsequent study,
Aratani et al. (19) identiﬁed a minimal transactivation
domain in RHA that is N-terminal to the conserved helicase
core, and is the domain that actually interacts with Pol II.
Through the use of a series of mutations in this activation
domain and in the conserved ATP-binding motif they showed
that Pol II recruitment was independent of ATPase activity.
However, mutants in both the transactivation domain and
the ATP-binding motif exhibited reduced CREB-dependent
transcriptional activity when co-transfected with plasmids
encoding CBP and a CRE-luciferase reporter (19). These
observations and the ﬁndings of Nakajima et al. (17) led to
the suggestion that RHA can independently regulate CREB-
dependent transcription either through ATP-dependent
mechanisms or through the recruitment of RNA Pol II.
RHA has been found to fulﬁll a similar bridging role
between the breast cancer-speciﬁc tumour suppressor
BRCA1 and the Pol II holoenzyme, interacting with the tran-
scriptionally active C-terminal domain BRCA1 (20–22).
Although BRCA1 is not itself a sequence-speciﬁc DNA-
binding transcription factor, it has been shown to be involved
in the transcriptional regulation of several genes involved in
DNA repair, cell cycle and apoptosis (23–25), presumably as
a coregulator of transcription through its interactions with fac-
tors in the transcriptional machinery. Interestingly, the inter-
acting region for BRCA1 on RHA is separate from that for
CBP implying that RHA also may interact speciﬁcally with
other factors involved in transcription from speciﬁc
promoters in response to particular signals. RHA was also
found to interact with the p65 subunit of NF-kB and to enhance
NF-kB-dependent transcription (26), while the Drosophila
homologue was shown to associate with, and stimulate the
transcriptional activity of, a region upstream of the roX2
gene, which is critical for dosage compensation (27). Addition-
ally, RHA has been shown to bind preferentially to the pro-
moter sequence of the p16
INK4a tumour suppressor gene in
cells with transcriptionally active p16
INK4a (28) and to be
recruited to the promoter of the multidrug resistance gene
(MDR1), upregulating transcription of the MDR1 gene (29).
Thus RHA may possess a more general transcriptional activity
through its association with CBP/RNA Pol II and also a more
speciﬁc activity through its interaction with speciﬁc transcrip-
tion factors and/or recruitment to speciﬁc promoters.
Figure 1. A schematic alignment of the human homologues of the DExD/H
box proteins considered in this review, highlighting the different lengths of
the divergent N- and C-terminal domains. The conserved helicase cores [in
yellow for DExH and light blue for DEAD (DEVD in the case of Ddx21)] are
shown, with the conserved motifs within them numbered (I–VI) and
highlighted in dark blue. The number of amino acids in the helicase cores
and the N- and C-terminal domains are indicated for each protein. The
functions of the conserved motifs are as follows: Motifs Q, I, II and VI
are required for ATP binding and hydrolysis; motifs Ia, Ib, III, IV and V are
thought to be involved in RNA binding. These are described more fully in the
contribution by Linder (2,3). The accession numbers for these proteins are
Dhx9- Q08211, Ddx20- Q9UH16, Ddx5- P17844, Ddx17- Q92841, Ddx21-
Q9NR30 and Ddx54- Q8TDD1.
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RHA in transcriptional regulation. However, there is also a
strong body of evidence showing that RHA is involved in
the expression/nuclear export of retroviral RNAs and in
pre-mRNA processing. RHA was found to interact both
with the constitutive transport element (CTE) of simian
type D retrovirus, being important for CTE-mediated nuclear
export (30,31), and with the Rev response element (RRE) of
HIV, stimulating both CTE- and Rev-dependent gene expres-
sion (32). A recent report has also indicated a role for RHA in
translation of selected mRNAs through interaction with their
50-untranslated region (33). Additionally, RHA has been
found to be associated with the survival motor neuron protein
(SMN), in Gems (nuclear bodies that are often associated
with Cajal bodies) and in cytoplasmic spliceosomal small
nuclear ribonucleoprotein complexes (snRNPs) suggesting a
possible involvement for RHA in the assembly of spliceo-
somes (34). Interestingly, studies on the Drosophila homo-
logue, Mle, showed that a speciﬁc mutation (mle
napts)i s
not involved in dosage compensation but, instead, appears
to result in aberrant splicing/exon skipping in a region of
the para Na
+ channel that is involved in RNA editing;
these ﬁndings suggest that it may be required to resolve
RNA secondary structures in this region (35).
Thus RHA and its Drosophila homologue Mle function in
several different cellular processes, including transcription,
RNA processing and export, through their interaction with
different components of the machineries involved in these
processes, via their unique N- and C-terminal domains
which lie outside the conserved helicase core [reviewed in
(36)]. A diagram, highlighting the proteins that RHA/Mle
interact with and the processes they are involved in, is
shown in Figure 2A.
DP103 (Ddx20)
DP103 (Ddx20) was originally isolated as a DEAD box pro-
tein that associated with the Epstein–Barr virus nuclear
proteins EBNA2 and EBNA3C, which play a role in the regu-
lation of transcription of both latent viral and cellular genes
(37). This protein was also independently isolated as
Gemin3, a protein that interacts with SMN and is a compo-
nent of the SMN complex in nuclear Gems (38), suggesting
a role for Gemin3 in snRNP assembly. As with RHA the
unique C-terminus of Gemin3 was required for interaction
with SMN. A similar interaction with SMN was later con-
ﬁrmed for the murine homologue of DP103 (39). Thus, at
an early stage, DP103 was suggested to be involved in both
transcriptional regulation and RNA processing; this is high-
lighted in Figure 2B, which also indicates the proteins that
have been shown to interact with DP103.
In recent years, however, most of the reports on DP103
have concentrated on its role in transcription and have pro-
vided more direct evidence for its role as a transcriptional
regulator. The murine DP103 homologue was identiﬁed in a
yeast two-hybrid screen as a protein that interacted with the
proximal transcriptional repression domain within the nuclear
steroidogenic factor SF-1, an orphan nuclear receptor that
regulates expression of genes essential for reproductive and
endocrine development (40). The interaction with SF-1
again was shown to occur through the C-terminal domain
of DP103, outside the conserved helicase core (Figure 1).
Moreover this domain was found to possess an autonomous
intrinsic transcriptional repression activity and to repress
the activation function of SF-1 (41). However, not all physio-
logical target promoters of SF-1 tested were repressed, sug-
gesting a measure of promoter speciﬁcity in repression by
DP103 (41). Interestingly it has been suggested recently
that DP103 mediates repression of SF-1 transcriptional activ-
ity by promoting sumoylation of SF-1 via the PIAS E3
SUMO ligases, which in turn results in subnuclear relocaliza-
tion of SF-1 to discrete nuclear foci (42).
The C-terminal domain of DP103 was also isolated as an
interacting protein for two other transcription factors from
yeast two-hybrid screens. Firstly, it was found to interact
with the N-terminal repression domain of the mitogenic Ets
repressor METS [a member of the ETS-domain transcription
factor family (43)], which is induced during macrophage dif-
ferentiation and represses transcription of Ets target genes
involved in Ras-dependent proliferation (44). The C-terminal
domain of DP103 was again demonstrated to have intrinsic
transcriptional repression activity and to be required for
the METS-dependent block in cell proliferation. Moreover
Table 1. Summary of the commonly used names and reported functions for RHA, DP103, p68 and p72
Ddx/Dhx
nomenclature
Other names Functions in
transcription
Other functions
Dhx9 RNA Helicase A (RHA)
Nuclear DNA Helicase II (NDHII)
Transcriptional coactivator-acting as bridging factor
between transcription factors/co-factors (17,20)
snRNP assembly (34)
Expression/nuclear export of retroviral
Drosophila maleless (MLE) Binding to promoters (29) RNAs (30–32)
Translation (33)
RNA editing (35)
Ddx20 DP103 Transcriptional repressor/corepressor-interacts snRNP assembly (38)
Gemin3 with repressors (40,41,44,45)
Ddx5 p68 Transcriptional coactivator/repressor; interacts with Pre-mRNA and pre-rRNA processing (56,58)
Dbp2 (yeast homologue for p68/p72) transcription factors/cofactors (64–67,69–71) Alternative splicing (59)
RM62/Dmp68 (Drosophila homologue) Transcriptional deactivation (72) mRNA decay (58)
RNAi (63)
Ddx17 p72 (Dbp2-yeast homologue) Transcriptional coactivator/repressor (65,71) Pre-mRNA processing (57)
Alternative splicing (60,61)
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deacetylases HDAC2 and HDAC5 implying that DP103 may
repress transcription through the recruitment of HDACs (44).
Secondly, DP103 was found to interact with the early growth
response 2 (Egr2/Krox-20) transcription factor, which is
important for myelination of the peripheral nervous system
and for establishing segmentation in the developing vertebrate
hindbrain (45). Again DP103 was shown to repress Egr2-
mediated transcriptional activation; however, this was not
observed for all Egr2-responsive promoters, suggesting that
this repression activity depended on the promoter context.
Since DP103 had been shown to interact with HDAC2 and
HDAC5, Gillian and Svaren (45) tested the effect of the
HDAC inhibitor Trichostatin A (TSA) on the ability of
DP103 to repress transcription. Using a range of reporter con-
structs they showed that, while TSA alleviated the transcrip-
tional repression of promoters of the Egr2 target genes Eph4A
and FGF2 when DP103 was co-transfected with Egr2, it had
no effect on the constitutively active GAL4-thymidine kinase
and GAL4-Adenovirus major late promoters when DP103
was tethered to a GAL4 DNA-binding domain. Thus DP103
repression of Egr2-mediated transcriptional activation
exhibits promoter speciﬁcity and is at least in part dependent
on HDAC recruitment. On the other hand the intrinsic tran-
scriptional repression function of DP103 appears to be
HDAC-independent, suggesting that there is more than one
mechanism for transcriptional repression by DP103.
The idea that DP103 may, at least partially, repress tran-
scription through HDAC recruitment is particularly exciting,
especially since DP103 was shown to repress SF-1 activity
through sumoylation [see above (42)]. Sumoylation often cor-
relates with transcriptional repression, which, at least in some
cases, is mediated through HDAC recruitment (46).
p68 (Ddx5) and p72 (Ddx17)
p68 (Ddx5) is one of the prototypic members of the DEAD
box family of proteins (47) and was one of the ﬁrst proteins
to be shown to exhibit RNA helicase activity in vitro (48).
p72 (Ddx17) was fortuitously isolated from an antibody
screen of a HeLa expression library and was found to have
remarkable similarity to p68, sharing 90% amino acid
sequence identity over the conserved core (49), although
the N- and C-termini are signiﬁcantly different. p72 and its
alternative translation initiation product p82 have themselves
been shown to have RNA helicase activity in vitro (50,51)
and p68 and p72 were subsequently shown to exist as het-
erodimers in cells (52). However the function of these pro-
teins remained elusive, although the expression of p68 was
shown to be growth and developmentally regulated and to
correlate with organ maturation/differentiation (53), p72
appeared to be down-regulated during development (54).
The ﬁnding that p68 was one of the proteins co-purifying
with spliceosomes in a mass spectrometric analysis of
spliceosomal complexes (55) suggested a role for this protein
in RNA splicing. This was subsequently conﬁrmed when it
was shown that p68 is an essential splicing protein which
acts at the U1 snRNA-50 splice site duplex (56). Interestingly
p72 was also found to co-purify with U1 snRNP (57). More-
over the yeast p68/p72 homologue Dbp2 was shown to be
Figure 2. Proteins interacting with (A) RHA/Mle, (B) DP103 and (C) p68/Dbp2, and the cellular processes in which they are involved, as examples to illustrate
the multifunctional properties of the DExD/H box proteins discussed in this review. RHA has also been shown to interact with the promoters of the MDR1 and
p16
INK4A genes; therefore these are also indicated.
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and p72 proteins have been shown to be important for
alternative splicing of the c-H-ras and CD44 genes, respec-
tively (59–61). Roles for DEAD (and DExH) box proteins
in pre-mRNA and pre-rRNA processing have been well docu-
mented (2,62). Interestingly, a study investigating proteins
associating with the Drosophila fragile X protein, FMR1,
has shown that the Drosophila p68 homologue (Dmp68/
RM62) co-puriﬁes with FMR1 and Argonaute 2 (a compo-
nent of the RNA-induced silencing complex) and is required
for RNAi (63), suggesting another potential function for p68.
Perhaps more surprising was the ﬁnding that p68 interacts
with and acts as a transcriptional coactivator for the nuclear
receptor estrogen receptor alpha (ERa) (64). This activity
was subsequently found to be shared by p72 (65). Activation
of gene expression by ERa is mediated by two autonomous
transcription activation domains, AF1 and AF2. AF1 func-
tions in a ligand-independent manner while the activity of
AF2 is regulated by estrogen binding, which results in a
conformational change in this domain and thus facilitates
coregulator recruitment. Since p68/p72 stimulates the
estrogen-induced activity of ERa and also interacts with ster-
oid receptor coactivator, SRC1, and the RNA coactivator,
SRA, it was suggested that p68 might coactivate ERa by
mediating interactions between ERa, AF1 and the AF2 coac-
tivator complex by direct binding to these coactivators (65).
This implies that p68 and p72, like RNA helicase A
(17,20), may act as a bridge between transcription factors/
coactivators, an idea that has been reinforced by other recent
reports. First, p68 was shown to interact with the transcrip-
tional coactivators CBP/p300 and RNA Pol II, stimulating
transcriptional activation mediated by CBP/p300 (66).
Second, it was found to interact with Smad3 [a member of
the Smad family of transcriptional activators that act as intra-
cellular effectors of TGF-b (67)] and to form part of a ternary
complex with Smad3 and CBP (68). Moreover, p68 was
shown to be recruited to the promoter of the natural ERa tar-
get gene, pS2, in the presence of estrogen (69), suggesting an
involvement for p68 in transcriptional initiation.
A recent report has demonstrated that p68 acts as a potent
coactivator for the tumour suppressor p53, a latent transcrip-
tion factor that is induced and activated in response to stres-
ses, such as DNA damage, and induces transcription of genes
involved in cell cycle arrest and apoptosis. Co-expression of
p68 potently stimulated transcription from p53-responsive
promoters. Furthermore RNAi suppression of p68 inhibited
the expression of p53 target genes in response to DNA dam-
age and p53-dependent apoptosis, suggesting a requirement
for p68 in the p53 response (70). This activity is speciﬁc
for p68 since RNAi suppression of p72 had no effect on
the induction of p53 transcriptional activity by DNA damage.
p68 was also found to be recruited to p53-responsive promot-
ers in response to DNA damage (70) echoing the ﬁnding for
p68/ERa in response to estrogen (69) and suggesting that p68
may play a role in transcriptional initiation, perhaps through
facilitating the recruitment of other transcription factors or
coactivators through its interaction with factors such as
CBP, p300, SRC1 and RNA Pol II (64–66). In addition to
their role as transcriptional coactivators, p68 and p72 have
been shown to have other functions as transcriptional repres-
sors: both proteins have been shown to interact with HDAC1
and to exhibit intrinsic promoter-speciﬁc transcriptional
repressor activity when tethered to DNA using the GAL4 sys-
tem (71). Interestingly, p68 and p72 showed subtle differ-
ences in their ability to repress transcription whereas p72
exhibited both HDAC-dependent and HDAC-independent
transcriptional repression activity. This is reminiscent of the
ﬁndings for DP103 (45). Another recent study, this time
with the Drosophila homologue, Dmp68, has suggested a
novel role for p68 in transcript clearance from transcription
sites and in transcriptional deactivation (72).
An interesting point from the studies of p68/p72 as tran-
scriptional coactivators/repressors was the ﬁnding that, in
most cases, RNA helicase activity was not required for
their function in transcriptional regulation. For ERa, although
the interacting region between p68/p72 and ERa included
part of the conserved helicase core and RNA binding was
important for ERa coactivation, p68 helicase activity per se
was not required (64,65). It is not yet clear whether the same
applies for p72. In the case of p53, a helicase inactive mutant
of p68 was able to stimulate p53 transcriptional activity as
efﬁciently as the wild-type protein (70). Similarly, RNA heli-
case activity did not appear to be required for p68 and p72 to
function as transcriptional repressors (71). These ﬁndings
thus suggest that the activity of p68/72 in transcriptional
regulation is distinct from their activity in RNA processing
and supports the idea that they are truly multifunctional pro-
teins with roles in several cellular processes. This is indicated
in Figure 2C for p68 and its yeast homologue Dbp2, which
was shown to be important in rRNA processing and nonsense
mediated mRNA decay (58).
RHII/Gua (Ddx21) and DP97 (Ddx54)
Other members of the DExD/H family shown to act as tran-
scriptional regulators include the DEVD subfamily protein
RHII/Gua (Ddx21) and the DEAD subfamily protein DP97
(Ddx54).
RHII/Gua was ﬁrst isolated as a nucleolar protein recog-
nized by an autoantibody from a patient with watermelon
stomach disease (73). Little was known about its function
until it was identiﬁed as an interacting partner for c-Jun
from a Tandem afﬁnity puriﬁcation/mass spectrometric anal-
ysis (74). This study went on to show that the C-terminal
domain of RHII/Gua interacts with the N-terminal transacti-
vation domain of c-Jun, a transcription factor which plays a
key role in the response of cells to stress, apoptotic and dif-
ferentiation signals. The interaction between RHII/Gua and
c-Jun was enhanced by anisomycin treatment, which activates
the c-Jun signalling pathway and results in a relocalization of
RHII/Gua from the nucleolus to the nucleoplasm. Moreover,
while overexpression of wild-type RHII/Gua had no effect on
c-Jun-dependent transcription, overexpression of ATPase/
helicase defective mutants or microinjection of anti-RHII/
Gua antibody inhibited c-Jun transcription activity in vitro,
suggesting that RHII/Gua is important for c-Jun transcription
activation and that RHII/Gua helicase activity is involved
in this function. Subsequently, RHII/Gua was found to
be required for the processing of 20S rRNA to 18S, indicating
an additional role for this helicase in rRNA processing
(75–77).
4210 Nucleic Acids Research, 2006, Vol. 34, No. 15DP97 was identiﬁed as a protein that interacts with the AF2
domain of ERa and of other nuclear receptors (78). Again the
interaction was shown to occur through the C-terminal
domain of DP97 but, in this case, was found to result in tran-
scriptional repression of ERa-regulated genes.
A role for DExD/H proteins in cell growth/cell cycle
regulation and cancer
For several years, reports demonstrating overexpression of
some DExD/H box proteins in tumour cell lines and tumour
tissues (79–83) have implied possible roles for these proteins
in cancer development, although it has not been clear whether
their association with cancer is causal or consequential.
Therefore, the demonstration that several DExD/H proteins
interact with proteins that are known to be involved in the
transcriptional regulation of genes involved in DNA repair
and cell growth/cell cycle control have highlighted poten-
tially important roles for DExD/H proteins in the develop-
ment of cancer. Some examples are discussed below.
RHA is the most extensively documented DExD/H protein
in terms of possible links with tumour development. Through
its interaction with BRCA1, RHA may play an important role
in the function of BRCA1 in the transcriptional regulation of
genes involved in DNA repair/genome maintenance, cell
cycle regulation and apoptosis (23–25). Moreover, the ﬁnding
that overexpression of a fragment of RHA that is known to
bind to BRCA1 gives a dominant negative mutant and causes
defects in ploidy and cytokinesis in mammary epithelial cells
suggests a possible co-suppressor function for RHA (84). Thus
RHA could be important in breast cancer development. Sev-
eral other reports have also suggested roles for RHA in cell
cycle or growth regulation and cancer through its function in
transcription. Examples include (i) the ﬁnding that RHA is
part of the MEF1 transcription factor complex which is
recruited to the MDR1 promoter and enhances transcription
of this gene in cancer cells, implying an involvement of
RHA in the development of resistance to chemotherapeutic
drugs (29), and (ii) the observation that RHA interacts with
the p65 subunit of NF-kB and is important in mediating
NF-kB transcriptional activity (26), suggesting that RHA
could play a role in the known functions of NF-kB as a pro-
moter of cell growth and survival or, as shown in some con-
texts, tumour suppression (85). Other possible connections
for RHA with cancer development are suggested by the ﬁnd-
ings that RHA (i) stimulates the exonuclease activity of the
Werner’s syndrome protein, which is important in DNA repair
and genome maintenance (86,87); (ii) preferentially interacts
with the promoter of the p16
INK4a tumour suppressor gene in
cells in which this gene is transcriptionally active, suggesting
another role for RHA in cell cycle control (28,88); and (iii)
is overexpressed in human lung cancers (89) and maps to the
prostate cancer susceptibility locus on chromosome 1q25 (90).
Several lines of evidence have suggested that p68 may also
play an important role in cancer development. The ﬁnding
that p68 coactivated ERa function (64) not only demon-
strated for the ﬁrst time a role for p68 in transcriptional regu-
lation but also highlighted a potential link with tumour
development. This was reinforced by reports showing
that p68 is overexpressed and abnormally modiﬁed in col-
orectal tumours (91), and that there are changes in p68
phosphorylation associated with transformation and abnormal
cell proliferation (92). Moreover, the ﬁnding that p68 stimu-
lates the transcriptional activity of the p53 tumour suppressor
and that RNAi depletion of p68 inhibits the induction of p53
target genes in response to DNA damage and p53-dependent
apoptosis (70) suggests that p68 may act as a tumour
co-suppressor for p53. Taken together these different lines
of evidence suggest that p68 may be important in cancer
development.
Other examples of DExD/H proteins having possible impli-
cations for cell growth regulation, as a result of their function
in transcriptional regulation, include DP103 and RHII/Gua.
DP103, through its interaction with the Ets repressor
METS, is important in blocking Ras-dependent cell prolifera-
tion (44). Moreover, it has been suggested that the interaction
of DP103 with the Epstein–Barr virus proteins EBNA2 and
EBNA3C (37) may interfere with the METS/DP103 interac-
tion and may contribute to transformation by this virus (44).
DP103 has also been shown to interact with the forkhead
transcription factor FOXL2 and to modulate its ability to
induce apoptosis (93). Similarly RHII/Gua, through its coac-
tivation of c-Jun transcriptional activity and promotion of
c-Jun-mediated neuronal differentiation (74), could play a
role in c-Jun mediated cell cycle regulation or apoptosis
(94,95).
CONCLUSION/PERSPECTIVES
DExD/H proteins as nucleation/bridging factors in
transcription complexes
DExD/H proteins have long been known to function as part of
large RNP complexes in processes such as pre-mRNA pro-
cessing, translation initiation and ribosome assembly (2).
Many of the studies that have demonstrated roles for these
proteins in transcription have shown that they function
through interaction with transcriptional coactivators/
corepressors. These ﬁndings have led to the suggestion that
DExD/H proteins may regulate transcription either by acting
as nucleating factors to recruit transcription factors and other
coregulators to the transcriptional initiation complex or by
stabilizing the initiation complex through interactions with
multiple factors in the complex (Figure 2). Importantly, as
discussed above for RHA (17,20), DP103 (44) and p68/p72
(65), these studies demonstrate, or at the very least suggest,
that they function through acting as adaptors or bridging fac-
tors between coactivators/corepressors and factors in the tran-
scriptional machinery. The idea that DExD/H proteins are
acting as bridging factors to regulate transcription is particu-
larly interesting when one considers that, in many cases, the
interacting regions on the DExD/H proteins lie outside the
conserved core, and could account for the high diversity
and speciﬁcity of interactions exhibited by these proteins.
Such diversity/speciﬁcity could be very important in the
cell’s response to different signals or stresses and the conse-
quent responses. A model suggesting how RHA or p68/p72,
by acting as adaptors between different components of the
transcription machinery, could assist in recruitment of other
factors or stabilization of the transcription initiation complex
at promoters is shown in Figure 3.
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The function of DExD/H box proteins in transcriptional regu-
lation is likely to be dependent on interacting transcription
factors, the signals they respond to, the promoter context
and the cellular environment. Importantly, for most of the
proteins discussed above, the regions interacting with tran-
scription factors and involved in transcriptional regulation
lie in the N- or C-terminal domains outside the conserved
‘helicase’ core. Moreover, in some cases at least, ATPase/
RNA helicase activity does not appear to be required for
their function in transcription. This strongly suggests that
their role in transcription is distinct from their role in other
processes, where they may act as bona ﬁde helicases or
unwindases, and indicates that these proteins have multiple
functions within the cell, some of which may be biochemi-
cally independent of their role as bona ﬁde helicases/
unwindases. For many years it has been suggested that,
while the conserved helicase core acts as a ‘motor’, the
unique N- and C-terminal domains impart speciﬁcity to the
interaction of these proteins with partner proteins, allowing
them to unwind speciﬁc substrates. However, the ﬁnding
that some DExD/H proteins have additional, possibly
helicase-independent, functions encoded by these N- and
C-terminal extensions strongly suggests that they are truly
multifunctional.
Another very interesting idea that emerges from these ﬁnd-
ings is that DExD/H proteins may be acting to ‘couple’ pro-
cesses such as transcription and RNA processing. In fact such
a suggestion was made by Auboeuf et al. (96) recently for
some coregulators of nuclear receptors, and by Bates et al.
for p68 (70). Since several of these proteins have been
shown to interact with factors from the transcriptional and
RNA processing machineries, one of their functions may be
to facilitate the recruitment of such factors. This is particu-
larly relevant since it is clear that mRNA processing events
(cap formation, splicing and 30 end formation/
polyadenylation) occur co-transcriptionally [reviewed in
(97,98)]. Therefore, the idea that RNA helicases, which
might be required to unwind RNA in later stages of gene
expression (e.g. splicing), are also functioning as part of the
transcription machinery (perhaps in an RNA helicase-
independent manner), to facilitate mature mRNA production,
is very exciting. It is tempting to speculate that some DExD/
H proteins might perform such ‘coupling’ functions partly
through their action as adaptor molecules. After transcrip-
tional initiation, they may also interact with the nascent
RNA molecule and with splicing factors and, possibly
through conformational changes, may be then released from
the transcription machinery to function in RNA processing.
For example, as discussed above, RHA has been shown to
associate both with components of the transcriptional
machinery and with the SMN complex in snRNPs (17,34),
although it is unclear whether the ‘pools’ of RHA molecules
associating with transcription and spliceosome complexes are
independent, or whether there is a transition from
transcription- to spliceosome-associated RHA. A particularly
interesting example of how a DExD/H protein might act to
couple transcription and pre-mRNA processing lies with
p68. This protein has been shown to be associated both
with the transcriptional machinery (64,66) and with spliceo-
somes (55), and to speciﬁcally interact with the U1 snRNA
at the 50 splice site (56,99); moreover, it has been
demonstrated to function in transcriptional initiation and
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Figure 3. Models for mechanisms by which DExD/H box proteins, such as RHA and p68/p72, could recruit components of the transcription machinery to
promoters or stabilize transcription initiation by acting as adaptor molecules or bridging factors, as suggested by the literature. Solid arrows indicate interactions
documented in the literature; heavy dashed arrows are bridging roles suggested from the known interactions; faint dashed arrows with query marks are implied
recruiting or bridging roles. (A) RHA through its interaction with CBP, RNA Pol II and BRCA1 has been suggested to act as a bridge between CBP and RNA Pol
II and between BRCA1 and RNA Pol II. Since BRCA1 also interacts with other transcriptional regulators its interaction with RHA could facilitate in recruitment
of RNA Pol II and other factors to the initiation complex or stabilize the initiation complex. (B) p68/p72 is known to interact with the AF1 domain of ERa and
p68 has been shown to interact with CBP and RNA Pol II, leading to the suggestion that p68/p72 may act as bridges between the ERa AF1 domain and
transcription factors interacting with the AF2 domain of ERa. p68/p72 could thus also enhance transcriptional activity by recruiting RNA Pol II to the initiation
complex or by stabilizing the complex.
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been found to associate with the general transcription factor
TFIIH and to regulate transcriptional initiation (100); this
association has been suggested to provide a potential link
between transcriptional initiation and mRNA processing
(101). Furthermore, it has been known for a long time that
the positioning of the ﬁrst intron and its 50 splice site have
a profound effect on transcription efﬁciency in transgenic
mouse models (102,103). More recent studies, using a retro-
viral minigene model, demonstrated that the 50 splice site of
the ﬁrst intron and its recognition by the U1 snRNA are
important for achieving efﬁcient transcriptional activation
(104), while U1 snRNP was shown to co-immunoprecipitate
with RNA Pol II (105). It is therefore tempting to speculate
that p68, by virtue of its interactions with components of
the transcriptional machinery (64,66) and with U1 snRNA
at the 50 splice site (99), could act as a coupling factor
between transcription and pre-mRNA processing. Addition-
ally, the recently suggested functions for the p68 Drosophila
homologue in transcript clearance and export (72) could
imply a further function for p68 in ensuring that the synthe-
sized mRNA is efﬁciently exported away from promoter
sites. Although this study examined the role of p68 in tran-
script clearance for gene deactivation, it is also possible
that p68 may play such a role to ensure efﬁcient promoter
clearance to increase efﬁciency of transcription. Moreover
such functions, as is the case for the known role for p68
in splicing (56), may require a helicase-active protein, in
contrast to its role in transcriptional initiation (64,70).
The picture now emerging on the function of many DExD/
H proteins is considerably more complicated than their acting
simply as motors to unwind RNA or displace proteins from
RNA. The fact that several members of this family appear
to be multifunctional and to have, in addition to their RNA
unwinding functions, other helicase-independent functions
suggests that the biological roles of these proteins may be
more complex than previously imagined. Additionally, the
idea that these proteins may act as adaptor molecules to
facilitate the formation, or improve the stability, of speciﬁc
protein complexes involved in transcription regulation
would allow them to have different functions in the cell,
depending on other factors present or the signals to which
the cell responds. This would be consistent with several of
these proteins being involved in cell growth and cell cycle
regulation. Moreover, the ability of DExD/H proteins to act
as adaptor molecules would also provide a means for them
to act as coupling factors between different processes in the
cell; this would impart a clear advantage in that it would
help to ensure both efﬁcient transcriptional activation and
correct processing to yield mature mRNAs. Studies to exam-
ine the roles of DExD/H box proteins in the formation and
modulation of transcription and splicing complexes should
help to elucidate possible mechanisms by which these pro-
teins could couple these different processes. Clearly there is
much work to be done and the next few years in this area
of DExD/H protein research should be very exciting.
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